Publisher
Springer International Publishing
Reference124 articles.
1. Abay, S. M., Deribe, K., Reda, A. A., Biadgilign, S., Datiko, D., Assefa, T., Todd, M., & Deribew, A. (2015). The effect of early initiation of antiretroviral therapy in TB/HIV co infected patients: A systematic review and meta-analysis. Journal of the International Association of Providers of AIDS Care, 14(6), 560–570.
2. Abdool Karim, S. S., Naidoo, K., Grobler, A., Padayatchi, N., Baxter, C., Gray, A., et al. (2010). Timing of initiation of antiretroviral drugs during tuberculosis therapy. The New England Journal of Medicine, 362, 697–706.
3. Aguiar, F., Vieira, M. A., Staviack, A., et al. (2009). Prevalence of anti-tuberculosis drug resistance in an HIV/AIDS reference hospital in Rio de Janeiro, Brazil. The International Journal of Tuberculosis and Lung Disease, 13, 54–61.
4. Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006). Restoring function in exhausted CD8 T cells during chronic viral infection. Nature, 439, 682–687.
5. Bell, L. C. K., & Noursadeghi, M. (2018). Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nature Reviews. Microbiology, 16, 80–90.